$85.94 meals Payment -- Johnson & Johnson to Dr. Brian Wright
Johnson & Johnson provided an $85.94 meal to an Orthopedic Surgeon for Tagrisso.
This page provides a detailed analysis of a $85.94 meals payment from Johnson & Johnson to Dr. Brian Wright. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $85.94 |
| Payment Type | meals |
| Payment Nature | Food and Beverage |
| Pharmaceutical Company | Johnson & Johnson |
| Physician | Dr. Brian Wright |
| NPI Number | 1098259641 |
| Physician Specialty | Orthopedic Surgery |
| Location | City, WA |
| Date of Payment | 2024-12-09 |
| Related Drug/Device | Tagrisso |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Johnson & Johnson made a $85.94 meals payment to Brian Wright, a Orthopedic Surgery specialist in City, WA. The payment was associated with Tagrisso. The payment of $85.94 from Johnson & Johnson to Dr. Brian Wright was for meals related to the drug Tagrisso. This meal payment occurred on December 9, 2024, in Washington state. The payment was categorized as 'Food and Beverage' under the 'meals' payment type.
Patient Guidance: What This Payment Means for You
This payment was for a meal provided by a pharmaceutical company; it is important to understand if this meal influenced prescribing decisions. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Meal payments to physicians are common across many specialties, but the specific drug mentioned (Tagrisso) is typically associated with oncology, not orthopedic surgery, which warrants further context.
Regulatory Context: Sunshine Act Requirements
Payments from manufacturers to physicians must be reported under the Sunshine Act to ensure transparency in the healthcare industry.
Related Topics
This payment is related to the following healthcare transparency topics:
- meals
- food-and-beverage
- johnson-johnson
- brian-wright
- tagrisso
- orthopedic-surgery
Understanding meals Payments
Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.
Frequently Asked Questions About This Payment
What was this $85.94 payment for?
This was a meals payment of $85.94 from Johnson & Johnson to Brian Wright, categorized as "Food and Beverage". It was associated with Tagrisso. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Brian Wright accept pharmaceutical money?
Yes, Brian Wright received this $85.94 payment from Johnson & Johnson. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Brian Wright's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this meals payment?
A meals payment of $85.94 is generally routine and common in the industry. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Orthopedic Surgery?
To compare this payment against Orthopedic Surgery averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Orthopedic Surgery physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Brian Wright's relationship with Johnson & Johnson?
The payment amount is relatively small, suggesting a single meal or a small group. This $85.94 meals payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Orthopedic Surgery?
The drug mentioned, Tagrisso, is an oncology medication, which may indicate the meal was related to educating physicians on its use.
What should patients do after learning about this payment?
This payment was for a meal provided by a pharmaceutical company; it is important to understand if this meal influenced prescribing decisions.
What else should I know about this meals payment?
The payment was made to an Orthopedic Surgeon, a specialty not typically associated with oncology drugs like Tagrisso.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.